Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bou Diarra"'
Autor:
Marc-Alain Widdowson, Kathryn E. Lafond, Justin R. Ortiz, Mbayame Nd Niang, Jonathan D. Sugimoto, Kathleen M. Neuzil, M. Elizabeth Halloran, Kristen D.C. Lewis, Aldiouma Diallo, John C. Victor, Bou Diarra
Publikováno v:
Clinical Infectious Diseases
Clinical Infectious Diseases, Oxford University Press (OUP), 2021, 72 (12), pp.e959-e969. ⟨10.1093/cid/ciaa1689⟩
Clinical Infectious Diseases, 2021, 72 (12), pp.e959-e969. ⟨10.1093/cid/ciaa1689⟩
Clin Infect Dis
Clinical Infectious Diseases, Oxford University Press (OUP), 2021, 72 (12), pp.e959-e969. ⟨10.1093/cid/ciaa1689⟩
Clinical Infectious Diseases, 2021, 72 (12), pp.e959-e969. ⟨10.1093/cid/ciaa1689⟩
Clin Infect Dis
BackgroundWe report results of years 2 and 3 of consecutive cluster-randomized controlled trials of trivalent inactivated influenza vaccine (IIV3) in Senegal.MethodsWe cluster-randomized (1:1) 20 villages to annual vaccination with IIV3 or inactivate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::510fa7d8b35a030a4e68f13c65f32a07
https://hal-amu.archives-ouvertes.fr/hal-03421327
https://hal-amu.archives-ouvertes.fr/hal-03421327
Autor:
Shannon L. Emery, Kathryn E. Lafond, Aldiouma Diallo, Justin R. Ortiz, Doudou Diop, Déborah Goudiaby, Bou Diarra, Sahar Z Zangeneh, Kristen D.C. Lewis, M. Elizabeth Halloran, Kathleen M. Neuzil, Mbayame Nd Niang, John C. Victor, Ousmane M. Diop, Cheikh Sokhna, Jonathan D. Sugimoto, El hadji Abdourahmane Faye, Marc-Alain Widdowson
Publikováno v:
Clinical Infectious Diseases
Clinical Infectious Diseases, 2019, ⟨10.1093/cid/ciz066⟩
Clinical Infectious Diseases, Oxford University Press (OUP), 2019, ⟨10.1093/cid/ciz066⟩
Clinical Infectious Diseases, 2019, ⟨10.1093/cid/ciz066⟩
Clinical Infectious Diseases, Oxford University Press (OUP), 2019, ⟨10.1093/cid/ciz066⟩
Background The population effects of influenza vaccination in children have not been extensively studied, especially in tropical, developing countries. In rural Senegal, we assessed the total (primary objective) and indirect effectiveness of a trival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df03d2a1c8f82777d484747d529d002a
https://europepmc.org/articles/PMC6821165/
https://europepmc.org/articles/PMC6821165/
Autor:
Aldiouma Diallo, Niranjan Kanesa-thasan, Sathie Cheikh, Kathleen M. Neuzil, Moussa Ndiaye, Djibril Diene, Jodi Feser, Kathryn E. Lafond, John C. Victor, Tofene Ndiaye, Marc-Alain Widdowson, Justin R. Ortiz, Bou Diarra, Assane Ndiaye
Introduction Effective, programmatically suitable influenza vaccines are needed for low-resource countries. Materials and methods This phase II, placebo-controlled, randomized safety and immunogenicity trial (NCT01819155) was conducted in Senegal usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6efc066d51ea0e7f943107815f88e462
https://europepmc.org/articles/PMC6327321/
https://europepmc.org/articles/PMC6327321/
Autor:
Olubukola T. Idoko, Aldiouma Diallo, Enricke Bouma, Adebayo Akinsola, Abraham Hodgson, Fadima Cheick Haidara, Samba O. Sow, Marie-Pierre Preziosi, Bou Diarra, Godwin Enwere, Beate Kampmann, Patrick Ansah
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background. The Meningitis Vaccine Project (MVP) was established to address epidemic meningitis as a public health problem in sub-Saharan Africa and, to that end, worked to develop a group A meningococcal conjugate vaccine, PsA-TT. Methods. Experienc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbb3373192b4e2ff443739051be8cba1
https://doi.org/10.1093/cid/civ596
https://doi.org/10.1093/cid/civ596
Autor:
Richard A. Adegbola, Julie Chaumont, Aldiouma Diallo, Marc LaForce, Elisa Marchetti, Cheryl M. Elie, Yuxiao Tang, Prasad S. Kulkarni, Godwin Enwere, Brian D. Plikaytis, Simonetta Viviani, Sanjay Juvekar, Varsha Parulekar, Ray Borrow, Fatoumata Diallo, Siddhivinayak Hirve, Olubukola T. Idoko, Lionel Martellet, Milagritos D. Tapia, Bou Diarra, Fadima Cheick Haidara, Helen Findlow, Marie-Pierre Preziosi, Ashish Bavdekar, Adebayo Akinsola, George M. Carlone, Samba O. Sow
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background. Mass vaccination campaigns of the population aged 1–29 years with 1 dose of group A meningococcal (MenA) conjugate vaccine (PsA-TT, MenAfriVac) in African meningitis belt countries has resulted in the near-disappearance of MenA. The vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b3c9bd3e3900cd1e557a67bff078efc
http://europepmc.org/articles/PMC4639491
http://europepmc.org/articles/PMC4639491
Autor:
Prasad S. Kulkarni, Aldiouma Diallo, Assane Ndiaye, Lionel Martellet, Flore Pallardy, Milagritos D. Tapia, Bou Diarra, Abraham Hodgson, Siddhivinayak Hirve, Fadima Cheick Haidara, Patrick Ansah, F. Marc LaForce, Olubukola T. Idoko, Sanjay Juvekar, Richard A. Adegbola, Simonetta Viviani, Beate Kampmann, Godwin Enwere, Elisa Marchetti, Julie Chaumont, Marie-Pierre Preziosi, Samba O. Sow, Marie-Francoise Makadi, Ashish Bavdekar, Adebayo Akinsola
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background. The group A meningococcal vaccine (PsA-TT) clinical development plan included clinical trials in India and in the West African region between 2005 and 2013. During this period, the Meningitis Vaccine Project (MVP) accumulated substantial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2afc2572f826768ab4af656e3b96ad3